New combo therapy trial offers hope for elderly esophageal cancer patients
NCT ID NCT07196345
Summary
This study is testing whether combining a cancer drug called TAS-102 with radiation therapy is safe and effective for older adults with advanced esophageal cancer. The first part finds the safest dose, and the second part checks how well that dose works to control the cancer. The goal is to see if this combination helps patients live longer and manages their disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, 250000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.